A first excellent example may become the recently developed non-invasive multitarget stool DNA test (CologuardTM) for colorectal cancer screening that includes besides KRAS mutation analysis, detection of the methylation status of the NDRG4 and BMP3 genes. The gene discussed is KRAS; the disease is colorectal cancer.